Delay in replacing the Pap smear with HPV screening is costing lives

October 4, 2018 by Alejandra Castanon, The Conversation
Credit: Iryna Inshyna/Shutterstock.com

It was established a decade ago that testing for the presence of HPV – the virus that causes cervical cancer – is a better cervical screening test than the Pap smear. Yet in England, the Pap smear is still used, and it's costing lives.

Current screening for is done through the collection, staining and microscopic examination of cells from the cervix ("cytology"). The stain used to assess collected cells was developed in the early 1950s by George Papanikolaou, hence the name: Pap . During screening, clinicians look for abnormal cells. If any are found, they remove them to stop cervical cancer developing. The cervical screening programme in the UK today was introduced in 1988, and it is estimated to save 2,000 lives a year.

In 1983, a German virologist called Harold zur Hausen discovered that HPV caused cervical cancer and the first HPV test was invented 15 years later.

Because having the virus is necessary for developing cervical disease, HPV testing is better than a Pap test at identifying those at risk. Also, a negative HPV test is more reassuring than a negative Pap test because cytology is more likely to produce "false negative" results – in other words, not showing disease when there is disease.

In 2003, the US was the first country to introduce HPV-based screening. At the time, Pap smear testing in the US was perceived to be of low quality, so they included HPV testing alongside to ensure better quality screening. Mexico introduced HPV testing in 2008 and Turkey in 2014 (these countries had no high-quality national cytology-based programme before the introduction of HPV testing).

The pace of change in the EU has been considerably slower. The Netherlands and Sweden introduced the HPV test in 2017, while Italy will finish deploying the test at the end of 2018.

An abnormal Pap test. Credit: Komsan Loonprom/Shutterstock.com

Public Health England and the NHS, who are responsible for the screening programme in England have, until recently, aimed to switch to the HPV test in April 2019, but are now working towards a deadline of December 2019. Introducing HPV testing into existing screening programmes has been much more complicated than expected.

England is by no means the only country that has experienced delays. The hard lesson to learn here is that much earlier planning is needed to ensure a timely introduction of better tests.

Given the effectiveness of the Pap smear, you might think that a short delay in replacing it with an HPV test would have minimal consequences. In fact, our latest research, published in the Journal of Medical Screening, shows that for every month HPV testing is delayed in England, the chance to stop 48 extra women from developing cervical cancer is missed.

The high cost of delay

For our study, we used a mathematical model to estimate the number of new cancer cases that would be diagnosed by 2030 in England, assuming that HPV testing replaces the Pap smear in 2020 rather than in 2019. We also calculated the life expectancy for this excess cancer.

We also used a measure of disease burden called QALY (quality-adjusted life years) to estimate the cost of the excess cancers. A QALY includes both the quality and the quantity of life lived following the diagnosis of . It is used to compare health interventions when deciding which is better value for money.

We calculated that a one-year delay in implementing HPV would lead to a loss of 1,595 quality-adjusted life years, with a value of £32m. In estimating the cost per QALY, we used conservative assumptions, making the huge cost of delayed introduction even more shocking. As such, it's vital that there are no further delays in the roll-out of HPV testing in England.

Explore further: Q&A: Women 65 and older may not need Pap tests

Related Stories

Q&A: Women 65 and older may not need Pap tests

September 21, 2018
Dear Mayo Clinic: I am way past my childbearing years and do not have any health problems. Do I need to continue getting Pap smears? At what age is this test no longer necessary?

Research informs new national cervical cancer screening recommendation

August 21, 2018
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective ...

HPV testing could cut cervical cancers by a third

June 14, 2013
(Medical Xpress)—Testing women for the human papillomavirus (HPV) first, instead of using the traditional cervical screening test to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer ...

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

HPV jab means women only need 3 cervical screens in a lifetime

November 10, 2017
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to a new study published in the International Journal of Cancer today (Friday).

Is the pap smear on the way out?

July 3, 2018
(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.

Recommended for you

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.